- Home
- ZBRA vs BMRN Comparison
ZBRA vs BMRN Comparison
Compare ZBRA & BMRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZBRA
- BMRN
- Stock Information
- Founded
- ZBRA 1969
- BMRN 1996
- Country
- ZBRA United States
- BMRN United States
- Employees
- ZBRA N/A
- BMRN N/A
- Industry
- ZBRA Industrial Machinery/Components
- BMRN Biotechnology: Pharmaceutical Preparations
- Sector
- ZBRA Industrials
- BMRN Health Care
- Exchange
- ZBRA Nasdaq
- BMRN Nasdaq
- Market Cap
- ZBRA 15.1B
- BMRN 12.1B
- IPO Year
- ZBRA 1991
- BMRN 1999
- Fundamental
- Price
- ZBRA $285.40
- BMRN $57.24
- Analyst Decision
- ZBRA Buy
- BMRN Buy
- Analyst Count
- ZBRA 10
- BMRN 22
- Target Price
- ZBRA $321.20
- BMRN $93.43
- AVG Volume (30 Days)
- ZBRA 581.7K
- BMRN 2.2M
- Earning Date
- ZBRA 04-29-2025
- BMRN 05-01-2025
- Dividend Yield
- ZBRA N/A
- BMRN N/A
- EPS Growth
- ZBRA 109.28
- BMRN 152.82
- EPS
- ZBRA 10.57
- BMRN 2.71
- Revenue
- ZBRA $5,114,000,000.00
- BMRN $2,950,227,000.00
- Revenue This Year
- ZBRA $7.55
- BMRN $12.27
- Revenue Next Year
- ZBRA $5.82
- BMRN $10.08
- P/E Ratio
- ZBRA $27.42
- BMRN $21.47
- Revenue Growth
- ZBRA 17.45
- BMRN 19.36
- 52 Week Low
- ZBRA $205.73
- BMRN $52.93
- 52 Week High
- ZBRA $427.76
- BMRN $94.85
- Technical
- Relative Strength Index (RSI)
- ZBRA 57.54
- BMRN 40.62
- Support Level
- ZBRA $278.51
- BMRN $57.11
- Resistance Level
- ZBRA $297.01
- BMRN $59.12
- Average True Range (ATR)
- ZBRA 6.47
- BMRN 1.27
- MACD
- ZBRA -0.46
- BMRN 0.06
- Stochastic Oscillator
- ZBRA 42.05
- BMRN 18.62
About ZBRA Zebra Technologies Corporation
Zebra Technologies is a leading provider of automatic identification and data capture technology to enterprises. Its solutions include barcode printers and scanners, mobile computers, and workflow optimization software. The firm primarily serves the retail, transportation logistics, manufacturing, and healthcare markets, designing custom solutions to improve efficiency at its customers.
About BMRN BioMarin Pharmaceutical Inc.
BioMarin is a global biotechnology company focused on developing and commercializing therapies for rare genetic diseases. BioMarin specializes in enzyme replacement therapies, gene therapies, and other advanced treatments aimed at addressing complex genetic disorders. The company has eight approved therapies for conditions including achondroplasia, phenylketonuria (PKU), hemophilia, and mucopolysaccharidosis. BioMarin has an expanding, yet relatively early-stage, pipeline of treatments in development.